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Abstract
Differentially from other kinds of Ras, oncogenic K-Ras, which is mutated approximately 30% of human cancer,
does not induce apoptosis and senescence. Here, we provide the evidence that oncogenic K-Ras abrogates p53
function and expression through induction of Ataxia telangiectasia-mutated and Rad3-related mediated Snail stabi-
lization. Snail directly binds to DNA binding domain of p53 and diminishes the tumor-suppressive function of p53.
Thus, elimination of Snail through si-RNA can induce p53 in K-Ras–mutated cells, whereas Snail and mutant K-Ras
can suppress p53 in regardless of K-Ras status. Chemicals, isolated from inhibitor screening of p53-Snail binding,
can block the Snail-mediated p53 suppression and enhance the expression of p53 as well as the transcriptional
activity of p53 in an oncogenic K-Ras–dependent manner. Among the chemicals, two are very similar in structure.
These results can answer why K-Ras can coexist with wild type p53 and propose the Snail-p53 binding as the new
therapeutic target for K-Ras–mutated cancers including pancreatic, lung, and colon cancers.
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Introduction
In human cancer, the oncogenic mutation of Ras family genes in-
cluding H-, N-, and K-Ras, is frequently detected [1]. In particular,
K-Ras mutation is frequent event in pancreatic cancer (80-90%),
lung adenocarcinoma (35%), and colon cancer (40%) [2–4]. How-
ever, in previous studies, it has been revealed that oncogenic Ras in-
duces senescence and apoptosis through p53 activation [5,6]. Thus,
without functional defect of p53, activated Ras cannot promote tumor
formation. Indeed, hepatocellular carcinoma, induced by oncogenic
H-Ras, is rapidly regressed by restoration of p53 [7,8]. However,
p53 can coexist with oncogenic K-Ras in human cancer tissues and cell
lines [2,9,10]. In a mouse model, the physiological level of oncogenic
K-Ras can evoke adenoma despite the intact p53 system [11,12].
These results suggest that K-Ras may have a unique function differen-
tially from other Ras (H- or N-Ras).
About the p53 regulation network, overexpression of Mouse double
minute 2 (MDM2) is one of the well-confirmed mechanisms for p53
suppression [13]. Because p53 is rapidly degraded by MDM2 that
promotes p53 ubiquitinylation and degradation, overexpression of
MDM2 and p53 mutation shows a mutually exclusive pattern [14].
However, MDM2 overexpression, which is achieved through DNA
amplification, is a rare event in human carcinoma (instead, MDM2
amplification is frequently detected in human and mouse sarcomas)
[15,16]. Another p53 suppression mechanism of human cancer is si-
lencing or deletion of p14/ARF, an inhibitor of MDM2 [17,18].
Thus, loss of p14/ARF results in p53 suppression through the hyper-
activation of MDM2. Moreover, the induction of p19/ARF (homolog
of human p14/ARF) has been suggested to be responsible for Ras-
induced p53 activation [19,20]. However, p14/ARF cannot be induced
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by oncogenic Ras in human cells, and it shows the p53-independent
methylation or deletion pattern in human cancer [21], suggesting
that in the human system, p14/ARF function is not responsible for
oncogene-induced p53 activation. Moreover, p14/ARF knock-out
mouse shows quite a different cancer spectrum with the p53-deficient
animal [22], also suggesting the independent role of both proteins.
As mentioned above, N- or H-Ras–mediated tumorigenesis is ac-
companied with loss of p53 function, whereas oncogenic K-Ras can
coexist with wild type p53. The purpose of this study was to answer
how it is possible. To do this, we assume that K-Ras might possess a
unique function that can permit the cell to escape p53-mediated cel-
lular senescence or apoptosis. In this study, we reveal that oncogenic
K-Ras suppresses p53 through the induction of Snail. Although Snail
is a transcriptional repressor [23], Snail, stabilized by K-Ras–Ataxia
telangiectasia-mutated and Rad3-related (ATR) pathway, binds to
and eliminates p53 in a transcription-independent mechanism. Fur-
thermore, we identify the chemicals that can block the interaction be-
tween p53 and Snail and can induce p53 expression in K-Ras–mutated
cell lines.
Materials and Methods
Isolation of Mouse Fibroblast and Immortalization
A 6-month-old male mouse was killed to collect fibroblast. After
isolation of lung, tissue was chopped and dissociated using culture-
mess. After 3 days of incubating in Dulbecco’s modified Eagle’s me-
dium (DMEM) containing 20% FBS, attached cells were seeded in
culture dishes and transfected with mutant H-, N-, and K-Ras using
JetPEI (Polyplus Transfection, New York, NY) following the manufac-
turer’s protocol. After 72 hours, we initiated selection using 400 μg/ml
of G418 containing DMEM.
Cell Culture and Reagents
Cell lines used in this study were obtained from the American
Type Culture Collection (ATCC, Manassas, VA) and were main-
tained in RPMI-1640 or DMEM containing 10% FBS. Antibodies
used in this study were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA) or Cell Signaling (p53-R, p-Erk; Danvers, MA).
Ras expression vectors and Snail vectors were provided by Dr. Chi SG
(Korea University) [24] and Hung M-C (University of Texas) respec-
tively [25]. p53 S46D and 46A were provided by Mayo LD (Case
Western Reserve University) [26]. Chemicals used in this study were
purchased from Calbiochem (San Diego, CA). Recombinant p53 was
obtained from Assay Designs (Ann Arbor, MI).
Immunostaining and Western Blot Analysis
For cell staining, we routinely washed and fixed with 100% Me-
OH and incubated with antibodies (first antibody (Ab): 1:200, over-
night at 4°C; secondary Ab: 1:1000, 2 hours at room temperature).
To detect secreted p53 and Snail, HCT116 p53−/− cells were trans-
fected with vectors for 24 hours in 1 ml of RPMI 1640 and fixed by
adding 1 ml of 2% paraformaldehyde (PFA) without washing. After
fixation, cells were washed briefly with PBS twice and incubated with
blocking buffer (PBS + anti–human Ab (1:500)) to eliminate non-
specific binding. After washing with PBS, cells were incubated with
anti-p53 and anti–Snail Ab and matched secondary Ab. For protein
analysis, we extracted protein using a radioimmunoprecipitation as-
say (RIPA) buffer and applied the sample to SDS-PAGE, and fol-
lowed the routine Western blot protocol. Immunoprecipitation
analysis was performed using the general protocol. In brief, cell lysate
was incubated first with Ab for 4 hours at 4°C and then with protein-
A/G–agarose for 2 hours. After centrifugation and washing three
times, the precipitated complex was subjected to SDS-PAGE/Western
blot analysis.
Transfection and si-RNA
For cell transfection, we used jetPEI according to the manufac-
turer’s protocol. Cells were incubated with DNA/jetPEI mixture
for 24 hours in complete media. For in vitro gene knock out, we
generated si-RNA against Snail [27] and MDM2 [28]. Using jetPEI,
we transfected si-RNA and checked the effect after 24 hours.
Far Western Blot and In Vitro Kinase or Binding Assay
To address direct binding between Snail and p53, we prepared the
membrane, which is loaded with recombinant p53 or Snail or p53-
transfected cell lysate through typical SDS-PAGE and gel transfer
method. After blocking with 5% nonfat dry milk, the membrane
was incubated with p53 or Snail-transfected p53−/− HCT116 cell
lysate for 4 hours at 4°C. After washing, the membrane was subjected
to typical Western blot procedure with p53 Ab or Snail Ab. For
in vitro binding, the recombinant p53 and GST-Snail were incubated
for 1 hour at 4°C with rotation; we performed immunoprecipitation
with p53 Ab or GST Ab and Western blot analysis with GST or p53
Ab. To examine the modification of Snail, 293 cells were used for
transfection. After fraction or lysis, lysates were incubated with GST
or GST-Snail for 1 hour at 25°C and were subjected into SDS-PAGE
and Western blot analysis. Antibodies against p–mitogen-activated
protein kinase (MAPK) and p–ataxia-telangiectasia mutated/ATR
substrates were obtained from Cell Signaling.
Recombinant Proteins and GST Pull-Down
Three human Snail fragments (residues 1-90, 91-112, and 113-
264) and p53 fragments (1-93 and 93-292) were expressed in Escher-
ichia coli as a GST fusion protein. Each fragment was loaded on to
GSH-agarose and then eluted using a buffer containing 20 mM re-
duced glutathione after extensive washing. The eluted fractions were
further purified using an anion exchange chromatography (HitrapQ;
GEHealthcare Biosciences, Piscataway, NJ). The recombinant human
p53 protein (residues 94-292) was expressed in E. coli using the vector
pET28A, which contains a hexa-histidine tag at the C-terminus. The
p53 protein was purified using Ni-NTA affinity and a size exclu-
sion chromatography (Superdex 200; GE Healthcare Biosciences,
Piscataway, NJ). To address the direct binding between p53 and Snail,
agarose bead–conjugated GST or GST-Snail was incubated with cell
lysate or His-p53 in RIPA for 45 minutes at 4°C. After washing with
PBS and RIPA, the precipitated protein was subjected to SDS-PAGE
and Western blot.
Chemical Screening
To isolate Snail-p53 binding inhibitor, we generated ELISA sys-
tem. We immobilized His-p53 (93-292) on a 96-well plate using
0.5% PFA. After drying and washing, we incubated with GST-
Snail with 0.1 μM of chemicals (final concentration). After a 1-hour
incubation, the 96-well plates were washed with TBS-T and were in-
cubated with anti–GST-Ab (1:10,000 for 45minutes) and anti–mouse-
IgG-HRP (1:50,000 for 30 minutes). After washing twice, plates were
incubated with 3,3′,5,5′ tetramethylbenzidine (TMB) solution and
Stop solution. Using the ELISA reader, we determined the value.
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Results
Oncogenic K-Ras Suppresses p53
To test our hypothesis, we tried to generate a stable cell line using
normal mouse fibroblast. Transfection of N-Ras or H-Ras induced
apoptosis or senescence (Figure W1A). This result is consistent with
others’ previous result that single oncogene or oncogenic Ras did not
produce immortalized cell [29,30]. However, K-Ras12V–transfected
cells were growing and were maintained until now (>6 months from
transfection of K-Ras12V; Figure W1A). Because we used the normal
adult lung fibroblast and selected the transfected cells using G418,
proliferating cells did not result from spontaneous immortalized cell.
To address how K-Ras–transfected cells overcame oncogene-induced
senescence and apoptosis, we examined the effect of K-Ras on p53
function. Forced expression of oncogenic K-Ras suppressed the p53
expression in wild type p53–containg cell lines (Figure 1A). To confirm
this, we measured the expression of exogenous p53 after cotransfection
with oncogenic Ras. Different from H- or N-Ras, K-Ras could evoke
p53 suppression, which was not blocked by si-MDM2 (Figure 1B).
We could also obtain the similar result from p53-deficient HCT116
Figure 1. Suppression of p53 by oncogenic K-Ras. (A) Oncogenic K-Ras suppresses endo-p53 in several kinds of cell lines. Cells were
transfected with K-Ras 12V or EV vector for 24 hours. (B) K-Ras but not H- and N-Ras suppresses p53 expression. Suppressed p53 is not
restored by si-MDM2. PC3 cells were transfected with the indicated vectors for 24 hours. Actin was used as the loading control. (C)
Transfection of oncogenic K-Ras but not wild type K-Ras suppresses the p53 expression. HCT116 p53−/− cells were used for trans-
fection with the indicated vectors for 24 hours. Actin was used as the loading control. WT and MT indicate wild type K-Ras and onco-
genic K-Ras 12V. (D) Nuclear p53 is eliminated by oncogenic K-Ras transfection but not by wild type K-Ras. HCT116 p53−/− cells were
cotransfected with p53 and wild type or mutant K-Ras for 12 hours. After fixation, cells were stained with anti-p53 (DO-1; green) and
DAPI (blue). p53 of mutant K-Ras–transfected cells was located in extra–nuclear position like vacuole. (E) DN-Ras can induce endoge-
nous p53 in K-Ras–mutated A549. However, HepG2 did not show p53 induction. Cells were transfected with the indicated amount of
DN-Ras vector for 24 hours. (F) Among our tested point mutant p53, p53 S46D shows the resistance to oncogenic K-Ras–induced sup-
pression. p53 22/23 mutant (mdm2 binding–deficient mutant) was also reduced by oncogenic K-Ras. (G) Oncogenic K-Ras can reduce
the mutant p53 expression. Similar to wild type p53, p53 R175H mutant expression was also reduced by oncogenic K-Ras. (H) Protea-
some inhibitor ALLN (50 μM for 4 hours) does not block the oncogenic K-Ras–induced p53 suppression. Also, MG-132 does not block
the p53 suppression (Figure W2 A).
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(data not shown). However, wild type K-Ras did not suppress p53 ex-
pression (Figure 1,C andD). Reduction of p53 occurred using K-Ras in
a dose-dependent manner (Figure W1B). Blocking of Ras activity
through dominant-negative Ras (DN-Ras) could increase the p53 ex-
pression only in K-Ras–mutated A549 but not in HepG2 (Figure 1E).
Because A549 is a p14/p16–deficient cell line [31], induction of p53
by DN-Ras was not related with the p14-MDM2 pathway. In other
kinds of wild type K-Ras cell lines (MCF-7 and MKN-45), we did
not observe the induction of p53 by DN-Ras (data not shown). This
result suggests that endogenous oncogenic K-ras suppresses p53 expres-
sion. However, DN-Ras did not show an obvious and synergic effect on
DNA damage–mediated p53 suppression (FigureW1C), implying that
a strong genotoxic stress could overcome the oncogenic K-Ras–mediated
p53 suppression. K-Ras–mediated p53 suppression was detected in
point mutant p53 (S46A, 22/23, and 175; Figure 1, F and G). How-
ever, p53 S46D, the active form of p53, showed resistance to K-Ras–
mediated p53 suppression (Figure 1F ). This result is consistent with
our previous result that genotoxin-induced p53 activation could over-
come K-Ras–mediated suppression (Figure W1C). Because the 22/23
mutant does not associate with MDM2 [32], we can confirm that
K-ras–mediated p53 suppression is achieved through an MDM2-
independent pathway. Proteasome inhibitors did not block the K-
Ras–mediated p53, also indicating the irrelevance of MDM2 or p53
ubiquitin system (Figures 1H andW2A).We also checked the effect of
MAPK signaling inhibitors on K-Ras–mediated p53 suppression.
However, blocking of the MAPK pathway did not abolish the effect
on K-Ras–mediated p53 suppression (Figure W2, B–E ). These results
implied that K-Ras–mediated p53 suppression would be achieved
through a novel pathway, independently from canonical Ras-MAPK
pathway or MDM2-mediated negative feedback loop.
Snail Is Responsible for K-Ras–Mediated p53 Suppression
To explore the molecular mechanism of p53 reduction, we checked
the interaction between p53 and K-Ras or localization of K-Ras. How-
ever, we did not observe the binding between p53 and K-Ras or nu-
clear translocation of oncogenic K-Ras (data now shown). Through
searching for literatures, we found that Snail can negatively regulate
p53 [27]. Because p53 should be inactivated during cancer progres-
sion [33], and Snail can promote epithelial-mesenchymal transition
(EMT) that permits the cancer cell to migration and metastasis
[23,34,35], we examined the relationship between p53 and Snail.
Moreover, the expression of Snail is elevated in reoccurred cancer,
where p53 should be inactivated [36]. This result encouraged us to
investigate the relevance of p53 and Snail. First, we monitored the ef-
fect of K-Ras on Snail expression and revealed that Snail could be in-
duced by K-Ras (Figure 2A). Next, we measured the effect of Snail
on p53 expression in cell lines. Overexpression of Snail could suppress
p53 in A549 andHepG2 cell lines, whereas Snail knock down induced
p53 only in A549 (oncogenic K-Ras–containing cell line) but not
HepG2 (Figure 2B). In addition, si-Snail could increase the sensitivity
to DNA damage agent (Figure W2F ). Thus, overexpression of Snail
could promote cell proliferation and render the resistance to DNA
damage–induced cell death (Figure W2G ). Snail could also suppress
the exo-p53 as well as endo-p53, similarly to K-Ras (Figure 2C ). A
more interesting feature was that Snail and p53 were reduced together
when they were cotransfected (Figure 2,D and E ) regardless of mutant
p53 (Figure 2F ). However, mRNA of Snail and p53 were not reduced
(Figure 2, C andD). We also examined the effect of Snail on p53 tran-
script. However, Snail did not reduce p53 mRNA (Figure W2H ).
These results indicated that although p53 and Snail were well-
confirmed transcriptional regulators, their reduction was irrelevant
with transcriptional regulation. In addition, elimination of Snail could
block the K-Ras–mediated p53 suppression (Figure 2, G and H ). We
could also obtain the similar result from exo-p53 (Figure W3, A and
B). These results indicate that K-Ras–mediated p53 suppression is
achieved trough Snail induction. To exclude the possibility of technical
artifact of cotransfection, we examined the expression of both proteins
from the early phase. Within 4 hours, oncogenic K-Ras could induce
p53, whereas p53 was reduced after 6 hours (FigureW3C ). This result
indicated that p53 suppression was not achieved by transfection arti-
fact but was an effect of transfected proteins. Reverse transcription–
polymerase chain reaction analysis suggested that Snail or p53 was
not regulated at the transcription level (FigureW3D).We also checked
the apoptosis and cell cycle in K-Ras/Snail–transfected cells. How-
ever, apoptosis and cell cycle inhibition were not obviously induced
by K-Ras/Snail (Figure W3E ; see 4′-6-Diamidino-2-phenylindole
staining in Figures 1D and 2E , and propidium iodide in Figure 2H ;
data not shown).We could also observe the reduction of p53 by K-Ras/
Snail in aphidicolin-treated cell (data not shown) suggesting that the
reduction of p53 was not linked to cell cycle. Next, we monitored
the effect of Snail on the half-life of p53 through cycloheximide pulse
chase. However, Snail did not shorten p53 half-life (Figure W3F ).
From our previous result (Figure 1F ), we showed the resistance of
p53 S46D against K-Ras–mediated suppression. Thus, we checked
the effect of Snail on the expression of p53 S46D and found out that
Snail, differentially from K-Ras, could suppress p53 S46D expression
(Figure W4A). To reveal the reason, we monitored the effect of p53
S46D on Snail expression and found that S46D could suppress Snail
expression at the transcription and translation levels (Figure W4B).
Thus, differentially from wild type p53, in which si-Snail could re-
store the p53 suppression, si-Snail did not induce p53 expression when
S46D was transfected (Figure W4C ). Our results indicate that under
certain stress condition, activated p53 by modifying at the serine
46 residue can overcome K-Ras–mediated suppression mechanism
by the repression of Snail transcript. This mechanism would be one
of the protecting role of p53 against K-Ras–mediated tumorigenesis.
However, until now, we did not know what kinds of cellular stresses
can overcome K-Ras–Snail–mediated p53 suppression by activating
p53 S46D. This result also provides the clue why, in a considerable
portion of human cancers, p53 should be mutated or deleted during
the transition from in situ carcinoma to metastatic advanced cancer
despite oncogenic K-Ras harboring cancers [2].
Induction of Snail Is Achieved through ATR
To address how K-ras induce Snail, we first examined the engage-
ment of AKT, because Ras can activate AKT, which can suppress
GSK-3β–mediated Snail destabilization [25]. However, AKT-KD
did not block the Snail or K-Ras–induced p53 suppression (Fig-
ure 3A). In contrast, suppression of ATR through si-RNA could
block the p53 suppression (Figure 3B). Indeed, Snail was increased
by ATR but not by ataxia-telangiectasia mutated (ATM) and nocoda-
zole treatment (Figure 3, C and D). In vitro kinase assay showed
that Snail was phosphorylated by ATR (Figure W4D). K-Ras, which
has been known to activate ATR [31], also increased p-Snail in an
ATR-dependent manner (Figure 3E ) and extended the half-life of
Snail (Figure 3F ). These results suggested that K-Ras regulated Snail
through ATR.
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Figure 2. Snail suppresses p53. (A) Forced expression of oncogenic K-Ras can induce Snail expression, similarly with ALLN treatment.
HCT116 p53− cells were incubated with ALLN for 6 hours or transfected with the indicated vectors for 24 hours. (B) Snail can regulate
endogenous p53, dependently on K-Ras status. Overexpression of Snail can suppress endogenous p53 in A549 and HepG2 (upper
panel). However, si-Snail–mediated p53 induction is detected only in A549 (lower panel) but not in HepG2. p21 shows similar expression
pattern with p53. Cells were transfected with the indicated vectors or si-RNA for 24 hours. (C) Forced expression of Snail can suppress
p53 expression. However, mRNA of p53 is not altered. HCT116 were transfected with the indicated vectors for 24 hours. (D and
E) Western blot analysis and immunostaining also show the reduction of p53 and Snail in cotransfected cell. When single vector–
transfected, we could observe the expression of Snail or p53. However, in cotransfected cell, the expression of both proteins was
obviously reduced. HCT116 p53−/− cells were transfected with the indicated vectors for 24 hours. However, mRNA of p53 and Snail
was obviously detected (lower panel of D). (F) Snail also suppresses the mutant p53 including R175H and 46A mutants. (G) Si-Snail can
block the reduction of endogenous p53 by oncogenic K-Ras. MCF-7 and HepG2 also show the reduction of endo-p53 by oncogenic
K-Ras, whereas si-Snail can block it. (H) Immunostaining also shows the inhibitory ability of si-Snail against oncogenic K-Ras–induced
p53 suppression as well as perinuclear localization. HepG2 cells were transfected with the indicated vectors or si-RNA for 24 hours.
After washing, cells were stained with anti-p53 (DO-1) and DAPI (blue; nucleus). We also compared the effect of si-MDM2 and si-Snail
on the K-Ras–mediated p53 suppression. However, si-MDM2 did not block the oncogenic K-Ras–mediated suppression of p53 (Fig-
ure zW3, A and B).
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Direct Interaction between Snail and p53
Our next question was how Snail suppressed p53. Because Snail is
a nuclear protein, and Snail and p53 disappeared when they were
cotransfected (Figure 2, D–F ), we checked the interaction between
them. From endo-IP, we found that these proteins could be associated
(Figure 4A). Far Western blot analysis and GST pull-down assay indi-
cated that Snail and p53 directly interacted with each other (Figure 4,
B and C ). Through similar approaches, we revealed that the DNA
binding domain of p53 and the middle region of Snail served as a bind-
ing domain (Figures 4, D–F, and W4, E and F ).
Identification of Specific p53-Snail Binding Inhibitors
If Snail-p53 binding was essential for K-Ras–mediated p53 sup-
pression in pathologic status, preventing p53-Snail binding would
reactivate p53 under the K-Ras–activated condition and blocking
p53-Snail binding would be a promising drug target. Thus, we devel-
oped the ELISA system and screened the binding blocker between
p53 and Snail (Figure W5, A and B). From approximately 150 kinds
of chemicals, we identified 3 as inhibitors of Snail and p53 (Fig-
ure W5C ). These chemicals showed a dose-dependent inhibition
of Snail and p53 binding (Figures 5A and W6A). To confirm this,
we performed the GST pull-down and measured the expression of
p53 and its targets after treatment of these chemicals. All of them
could block the interaction of p53 and Snail and induce p53 expres-
sion (Figures 4B and W6B). We could also observe the induction of
p53 up-regulated modulator of apoptosis and p21 by treatment of
these chemicals (Figure 5C ). A more interesting feature was that in-
duction of p53 was detected only in K-Ras–mutated cells but not wild
type K-Ras–harboring cells (Figure 5D). The similar structure of quer-
cetin and morin suggested that our screening system was reliable
(Figure W5C ). Although these chemicals were isolated from natural
compounds, they would serve as an initial compound for generating
Figure 3. Requirement of ATR activity in K-Ras–induced Snail stabilization. (A) KD-AKT does not block the K-Ras or Snail-mediated p53
suppression. However, si-Snail can block the K-Ras and Snail-mediated p53 suppression. (B) Si-ATR can block the K-Ras–mediated p53
suppression. Reduction of p53 by oncogenic K-ras is completely blocked by si-ATR. (C) Forced expression of ATR can induce Snail ex-
pression. However, ATM does not induce Snail. p-H2A.X was used for monitoring of ATM/ATR activity. The 293 cells were used for trans-
fection. (D) Nocodazole strongly induces Snail expression in nucleus as well as whole cell lysate (WCL). (E) K-Ras induces the Snail
phosphorylation. To examine the ATR-mediated Snail phosphorylation, we transfected si-control, ATM, and ATR into 293. After IP with
Snail, we monitored the phosphorylation of Snail using p-ATM/ATR substrate Ab. Increase of p-ATM/ATR by K-Ras is reduced by si-ATR
but not ATM. (F) Pulse chase analysis shows that oncogenic K-Ras can expend the half-life of Snail. Consistent with previous literature, half-
life of Snail seemed to be approximately 20minutes. However, oncogenic K-Ras can increase the half-life of Snail for more than 1 hour. The
293 cells were transfected with the indicated vectors for 24 hours and incubated with ALLN for 2 hours. After washing with serum-free
medium, we blocked the de novo synthesis using CHX (5 μg/ml) for the indicated time and measured the expression of Snail.
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an anticancer drug through sequential modification. Finally, we checked
the effect of our chemicals on Snail-mediated p53 suppression. p53 re-
duction by cotransfection of Snail was blocked by the treatment of che-
micals by nos. 3 and 9 (Figure 5, E and F). These results suggested that
blocking of p53-Snail interaction could restore the p53 expression. We
also examined the effect of these chemicals on cell proliferation using try-
phan blue staining. These chemicals could obviously suppress cell prolif-
eration in A549, whereas they did not show an antiproliferating effect on
MKN-45 (K-Ras wild type cell; Figure W6C). In addition, ferulic acid
could evoke cell death in K-Ras–mutated cells (Figure W6D). Moreover,
quercetin (no. 2) was identified as an inhibitor of Snail-p53 interaction.
The antitumoral effect of this chemical has been proposed in epidemio-
logical studies. In particular, this chemical showed a prevention effect
on pancreatic cancer [37,38]. This fact is consistent with our result be-
cause oncogenic mutation of K-Ras is frequently detected in those types
of cancer.
Discussion
In this study, we showed that K-Ras could suppress p53 function
(Figure 6). K-Ras is frequently mutated in human cancer. In pancreatic
cancer, more than 80% of cancers and adenomas possess or are initiated
by the active mutation of K-Ras [2,4]. In contrast, the H- or N-Ras
mutation rate is relatively lower than that of K-Ras [2], suggesting that
the tumorigenic property or tumor-promoting force of K-Ras may be
Figure 4. Direct binding of Snail and p53. (A) Immunoprecipitation between p53 and Snail. In p53-deficient cells, Snail and p53 are not
detected. In contrast, Capan-1 (K-Ras–mutated cell) shows an obvious interaction between them. DU145 shows weak interaction. For
this analysis, we performed IP with p53 DO-1 Ab and checked the coprecipitated p53 and Snail using p53 rabbit antibody and Snail Ab.
(B) Far Western blot analysis. To address the interaction, we transfected EV or p53 vector into p53-deficient HCT116 and prepared the
GST- or GST-Snail–loaded membrane through typical SDS-PAGE and gel transfer protocol. The membrane was incubated with blocking
buffer and cell lysate (10% cell lysate in 3% nonfat dry milk containing TBS-T). After washing, the membrane was incubated with p53 Ab.
(C) GST pull-down shows the direct interaction of p53 and Snail. Agarose-conjugated GST or GST-Snail was incubated with recombinant
p53 in RIPA buffer for 1 hour. After washing, precipitated protein was subjected to SDS-PAGE and Western blot with the indicated Abs.
(D) Middle region of p53 is responsible for interaction with Snail. Using GST-fused N-p53 (1-93) and M-p53 (93-292), we performed the
GST pull-down. Middle region of p53 was bound to Snail. Input indicated amount of Snail protein using for GST pull-down. (E) Middle
region of Snail is responsible for p53 binding. Agarose bean conjugated GST or GST-Snail fragments were incubated with His-p53 and
subjected into SDS-PAGE and Western blot with His and GST. (F) Diagram of the binding domain. p53 DNA binding domain and Snail
middle region are interacted with each other.
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better than that of other Ras. However, the MAPK-activating or cell-
proliferating ability of three kinds of Ras is known to be similar to each
other [1,3]. These facts imply that there is an additional and unique
function of K-Ras that may contribute to tumor progression. On the
basis of our result, we propose that p53 suppression is the unique func-
tion of oncogenic K-Ras. According to previous observations, elimina-
tion of oncogenic K-Ras can induce p53 despite themutant p53 cell line
[39]. These results are exactly consistent with our result that oncogenic
K-Ras can suppress wild type and mutant p53 (Figure 1, F and G ).
We also reveal that K-Ras–mediated p53 suppression is achieved
through Snail (Figures 2A and 6). Snail has been known as a tran-
scriptional suppressor and a key regulator during embryonic develop-
ment (cell migration and EMT). Owing to its EMT-promoting
function, overexpression of Snail is frequently detected in advanced
cancer or metastatic carcinoma [23,35–37]. However, as shown in
Figure 3F and other’s report [25], protein half-life of Snail is too short
to perform the transcriptional repression. In fact, we did not observe
the obvious reduction of E-cadherin, a well-known target gene of
Snail [36], by overexpression of Snail (data not shown). Therefore,
we assume that the rapid turnover of Snail is related with its onco-
genic function. In fact, under the presence of p53, Snail expression
is more significantly reduced (Figure 2F ). This result indicates that
posttranslational reduction or low expression of Snail in cell, despite
the sufficient mRNA expression (Figure 2D), would be related with
p53 reduction. Our result may explain why Snail overexpression
shows the reoccurrence of tumor from ionizing radiation (IR) and
chemotherapy [37,40]. For the successful reoccurrence, tumor should
obtain the resistance to DNA damage–induced apoptosis. Thus, the
overexpression of Snail may render the resistance to DNA damage
through p53 suppression.
Figure 5. Blocking of Snail-p53 binding induces p53 function in K-Ras––mutated cells. (A) Dose effect of chemical on His-p53-Snail
binding. Increase of the OD value at a high concentration of no. 9 would be due to color of this chemical. The IC50 value of these
chemicals was approximately 1 μM. (B) GST pull-down assay showed the reduction of binding between p53 and Snail. (C) These che-
micals can induce p53 target genes (PUMA and p21) in A549. (D) These chemicals induce p53 in A549 but not in MKN-45. Each cell line
was incubated with 100 nM of chemicals for the indicated time. (E) Nos. 3 and 9 can block the Snail-mediated p53 suppression. Dis-
appearance of p53 by cotransfection with Snail in PC3 was blocked by treatment of morin (no. 3) and feulic acid (no.9). (F) Immuno-
staining of p53 also shows the induction of p53 by morin and feulic acid in Snail-transfected cells. PC3 was transfected with the
indicated vectors for 24 hours with/without chemicals.
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Until now we do not know the detailed mechanism of the p53 re-
duction by Snail. Although we have checked several kinds of possi-
bilities including ubiquitin-mediated degradation, transcriptional
repression, and shortening of p53 half-life (Figure W2), we did not
obtain a clear mechanism. These negative results suggest that a novel
p53 suppression mechanism would be present in the Snail-mediated
p53 reduction. In fact, we recently observed the p53 in vesicle-like
structure in Snail-transfected cells (data not shown). This feature
may provide the clue to reveal the p53 suppression mechanism.
We also reveal that Snail is obviously induced by ATR activity
(Figure 3C ). Because ATR is activated by DNA damage [41], IR or
chemotherapy may also induce Snail, resulting in the suppression of
p53. Although IR mainly activates ATM [42], several kinds of litera-
tures show the induction of ATR. Thus, activation of ATR, despite
p53 induction ability through Chk1-mediated phosphorylation
[41,42], may confer the possibility of reoccurrence. In fact, elimina-
tion of si-Snail can extend UV-mediated p53 activation (our un-
published data; data now shown).
In this study, we reveal that p53 and Snail form the very strong
complex that promotes reduction of both proteins. Their binding is
achieved through DNA binding domain of p53 and middle region of
Snail (Figure 4F ). However, why their binding has not been detected
for a long time is mysterious. Concerning this, we assume that owing
to the rapid elimination of interacted p53 and Snail, their binding
has not been easily detected (Figures W3C and 3F ).
Thus, it is very difficult to prove that Snail suppresses p53 through
direct interaction in response to oncogenic K-Ras because of the
rapid disappearance of p53 and Snail complex. Therefore, we tried
to identify the p53-Snail binding inhibitor. If the inhibitor blocks
the p53-Snail binding, p53 will be stabilized or increased in K-
Ras–mutated cell. In contrast, normal cells will not induce p53 be-
cause p53 is not eliminated by K-Ras or Snail. As described, we have
generated the ELISA-based screening system and isolated three com-
pounds (Figure W5). Interestingly, two chemicals (quercetin and
morin) have a very similar structure. In our previous study, we have
screened the p53 activator in K-Ras–mutated cells through Western
blot–based assay system (our submitted data). From this independent
analysis, quercetin has been identified as a specific activator of p53
in K-Ras–mutated cells. Considering these results, quercetin or simi-
lar chemicals would possess a p53-inducing ability through blocking
of Snail-p53 binding.
Although quercetin or its derivatives are natural compounds and
show broad biologic effect, it may be possible to generate a specific
inhibitor against Snail-p53 binding through further modification or
development. Blocking of Snail-p53 binding induces p53 in a K-Ras–
dependent manner (Figure 5) strongly suggests that oncogenic K-Ras
suppresses p53 through Snail-p53 binding. Moreover, our chemicals
can induce p53 target genes (Figure 5F ) implying that they can serve
as a basic platform for specific anticancer drug development. Recently,
we are performing a second chemical screening and getting more
Figure 6. Diagram for summary. When K-Ras is activated by a genetic mutation, ATR is activated and promotes p53 expression. Con-
versely, ATR induces Snail and suppress p53. Despite this balancing, mutant K-Ras can escape from p53-induced growth suppression
and drive the cell to tumor. Thus, blocking of Snail-p53 binding can re-store the tumor-suppressive role of p53 in response to oncogenic
K-Ras and Ras-induced replication stress.
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effective compounds that also show K-Ras–specific p53 induction at
0.5-μM ranges.
Our results indicate that oncogenic K-Ras blocks the p53 activation
through the induction of Snail, which suppresses p53 through direct
interaction (Figure 6). This is achieved through K-Ras–mediated ATR
activation that has been previously reported [31]. On the basis of this
mechanism, cancer cells may escape from p53-induced apoptosis and
senescence despite K-Ras mutation.
Taken together, our novel pathway, that is, Snail-mediated p53 suppres-
sion, would be a useful target for anticancer drug development, in partic-
ular, K-Ras–mutated cancers such as pancreatic, lung, and colon cancers.
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Figure W1. Oncogenic K-Ras suppresses p53 expression. (A) Immortalized primary mouse lung fibroblast by K-Ras. H-Ras and N-Ras did
not produce the immortalized cell. Pictures were taken after 1 and 3 months from G418 selection. K-ras–transfected cells have been
maintained until now. (B) Transfection of oncogenic K-Ras reduces the p53 expression as dose-dependent manner (1, 2, 4 μg/ml),
whereas wild type K-Ras induces it in a similar manner. Expression of p21 was used for control of p53 activity. HCT116 cells were
transfected for 24 hours with the indicated vectors. (C) Dominant-negative Ras can induce p53 expression in the A549 cell line. However,
DN-Ras does not show a clear synergic effect with genotoxic stress on p53 induction. A549 cells were treated with adriamycin (0.2 μg/ml)
and Etoposide (10 μM) for 2 hours.
Figure W2. Oncogenic K-Ras–mediated suppression of p53 is not blocked by chemical inhibitors. (A) MG132 does not block the p53
reduction. MG132 (50 μM) was treated 4 hours before harvesting 24 hours after transfection in HCT116 p53−/− cell. (B) Chemical inhibi-
tors (Raf kinase inhibitor, 10 μM; p38 inhibitor, 1.2 μM) do not block the K-Ras–mediated p53 suppression. In contrast, (C) chemical in-
hibitors of Ras downstream kinase (U0126, 1 μM; PD98058, 10 μM) do not block the oncogenic K-Ras–mediated p53 suppression. (D)
OtherMAPK inhibitors (SB202190, 10 μM) and TbR kinase inhibitor (SB431542, 10 μM) also show no effect on oncogenic K-Ras–mediated
p53 suppression. (E) DN-Ras can block the K-Ras–mediated p53 suppression. (F) si-Snail can induce p53 in oncogenic K-Ras harboring A549
and enhance the sensitivity to adriamycin. (G) Effect of Snail on cell proliferation and apoptosis. A549 cells were transfected with Snail and
incubated for 3 days with or without adriamycin (0.2 μg/ml). After fixing with 1% PFA, attached cells were visualized by tryphan blue stain-
ing. (H) Snail does not suppress p53 transcripts. To examine the possibility that Snail represses p53 transcripts, we performed reverse
transcription–polymerase chain reaction in Snail or EV-transfected A549. However, Snail did not reduce p53 transcripts. GAPDHwas used
for control. Cells were transfected with the indicated amount of Snail for 24 hours.
Figure W3. Snail is a critical mediator for oncogenic K-Ras–mediated p53 suppression. (A) Blocking of Snail through si-Snail can eliminate
oncogenic K-Ras-induced p53 suppression, whereas si-MDM2 cannot block it. (B) Immunostaining analysis also shows the similar result
that si-Snail can block the p53 reduction, whereas si-MDM2 cannot block it. (C) Overexpression of K-Ras/Snail can induce p53 at 4 hours.
However, p53 expression is rapidly reduced from 6 hours. (D) Induction of Snail by oncogenic K-Ras is not achieved by transcriptional
regulation. (E) Reduction of p53 by K-Ras/Snail occurred from early time. p53 reduction is detected from 12 hours after transfection. How-
ever, caspase 9 is not decreased. Induction of p21 is detected from 24 hours after transfection of p53. p53− HCT116 cells were cotrans-
fected with p53 and Snail/K-Ras for the indicated time. (F) Cyclohexamide chase analysis. To test that Snail can reduce the half-life of p53,
we performed the CHX pulse chase. However, Snail did not show an obvious effect on the half-life of p53. Cells, transfected with Snail,
were incubated with CHX for the indicated time and were subjected to Western blot analysis.
Figure W4. Direct interaction of Snail and p53. (A) Snail can suppress p53 S46D. Differentially from oncogenic K-Ras, Snail can suppress
the p53 S46D expression. The p53-deficient HCT116 cell was cotransfected with p53 S46A or S46D and Snail or K-Ras for 24 hours. (B)
In p53 S46D–transfected cells, Snail expression is suppressed. This result can provide the explanation to the question why p53 S46D
shows the resistance to oncogenic K-Ras–mediated suppression. (C) Although si-Snail can restore the wild type p53 expression, it does
not show the additional effect on expression of S46D. (D) ATR phosphorylates Snail in cytosol. To address how ATR regulated Snail, we
performed an in vitro kinase assay using si-ATR–transfected 293 cell lysate and GST-Snail. When the K-ras–transfected cell lysate was
added to GST-Snail, we can detect p-ATM/ATR substrate Ab reaction, whereas si-ATR eliminates it. Although the p-MAPK substrate Ab
recognizes Snail, it is not altered by si-ATR or K-Ras. Cells were divided into two fractions using a cell fraction kit. Actin was used as the
loading control. (E) Far Western blot analysis. GST-fused Snail fragments were loaded in SDS-PAGE and transferred into a polyvinylidene
flouride membrane. After blocking, the membrane was incubated with recombinant p53 and p53 Ab. Snail middle region (91-112) shows
the interactionwith p53. (F) FarWestern blot analysis. GST- or GST-Snail–loadedmembranewas incubatedwithHis-p53 (94-292) and Anti-His
Ab. Snail M is detected by His-p53.
Figure W5. Identification of Snail-p53 binding inhibitor. (A) Using ELISA, we measured the effect of chemicals, which were obtained
from the Aging Tissue Bank of Pusan National University on p53-Snail binding. Some chemicals reduced OD to basal level. (B) Result of
ELISA of second set. Chemical no. 2 was used as a positive control. (C) Chemical structures of candidates. Quercetin and morin show a
very similar structure.
Figure W6. Effect of chemicals. (A) Dose-dependent reduction of OD. (B) Three chemicals can induce p53 in a time-dependent manner
in HCT116. (C) To examine the effect of our chemicals on cell proliferation, we performed the trypan blue staining. A549 and MKN-45
cells were incubated with the indicated chemicals for 3 days. After washing and fixing, cells were visualized by tryphan blue staining.
Proliferation of A549 was obviously reduced by chemicals, whereas MKN-45 did not show significant inhibition by them. (D) Among the
chemicals, we examined the apoptotic potential of ferulic acid in A549 and MKN-45 cell line using TB staining. Cells were incubated with
0.1 μM of ferulic acid for 24 hours, and apoptosis was measured using TB staining–positive cells.
